IDEXX Laboratories, Inc. provided earnings guidance for the year 2022. For the year, the company expected to reported revenue of $3,305 million to $3,385 million and EPS to be $7.77 to $8.05.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
495.2 USD | +0.29% | +3.30% | -11.00% |
Apr. 01 | Elanco Animal Health Appoints Two Ancora Holdings' Nominees to Board | MT |
Apr. 01 | Elanco appoints two directors after settling with activist Ancora | RE |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Earnings Guidance for the Year 2022